Trial Profile
The efficiency and side-effect of dasatinib in the treatment of primary myelofibrosis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 20 Jun 2016 New trial record